Efficiency of Laferobionum Application in Children with Recurrent Bronchoobstructive Syndrome, Who Often Suffer from Respiratory Diseases

Abstract

The paper presents the results of the study on the efficacy of Laferobionum application in children with bronchial asthma, who often suffer from acute respiratory diseases (ARD). It is found that the inclusion of Laferobionum in complex of treatment and prevention in this group of children helps to reduce the incidence of ARD by 2.6 times, to reduce the incidence of bronchial obstruction episodes on the background of ARD by 2.8 times, to decrease the duration of bronchial obstruction. Under the influence of treatment with Laferobionum we have noted a tendency towards normalization of immunity parameters, increase in the content of interferon gamma, and decrease in the concentration of interleukin-4, the activation of antioxidant protection.

Keywords

• children
• bronchoobstructive syndrome
• recombinant interferon α-2b
• immunity
• efficacy of treatment